EU proposes reforms for general pharma legislation

EUROPE – The EU Commission has proposed reforms to the general pharmaceutical laws that seek to ensure a future-proof and crisis-resistant medicines regulatory system. The review of the EU’s general pharmaceutical legislation is a key component of the European Commission’s pharmaceutical strategy, released in November 2020. In its review, the Commission is looking at potential reforms in a variety of areas, including unmet medical needs, improving access to and affordability of medicines, addressing antimicrobial resistance, ensuring the security of medicine supply, adapting the regulatory approach to account for “novel products,”…

Read More

First batch of UK, Kenya healthcare agreement beneficiaries set to leave by end month

KENYA – The first batch of Kenyan nurses set to join the UK healthcare workforce will leave at the end of this month. Kenya will send 20,000 nurses on a three-year contract in an agreement signed between the two countries when President Uhuru Kenyatta visited the UK in July. The bilateral agreement was signed on July 29 for collaboration in the healthcare workforce. It permits Kenyan healthcare professionals to work for the National Health Service. The Labor ministry, through the National Employment Authority, has been mandated to recruit qualified nurses…

Read More

Glenmark’s European strategy takes a big leap with Tavulus launch in Spain

INDIA – Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, today announced the launch of Tavulus, a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) in Spain for the treatment of chronic obstructive pulmonary disease (COPD). COPD is a long-term condition that causes lung inflammation, lung tissue damage, and airway narrowing, all of which make breathing difficult. Studies show that nearly 2.5 million people in Spain suffer from COPD. Glenmark will sell the powder under the brand name Tavulus. Tavulus is expected to help a large number of…

Read More

Aga Khan Hospital donates ventilators to Kenya’s top public health facilities

KENYA – Aga Khan University Hospital, Nairobi (AKUH) has donated five ventilators to Kenyatta National Hospital (KNH) and Kenyatta University Teaching, Referral & Research Hospital (KUTRRH) to boost their COVID-19 response. KNH received three ventilators while KUTRRH will get two ventilators. AKUH also handed over 7,000 COVID-19 testing and extraction kits to the Ministry of Health. The donation is valued at over Sh25 million. It is part of the European Union-funded project “Aga Khan Development Network (AKDN) Regional Eastern Africa COVID-19 Response Partnership” that aims at improving systemic, gender-sensitive responses…

Read More

KNUST Hospital opens ultra-modern Dental Clinic for quality healthcare

GHANA – A state-of-the-art Dental Clinic designed to augment dental healthcare and the clinical training of Dental Students, has been inaugurated at the Kwame Nkrumah University of Science and Technology (KNUST) Hospital, in Kumasi, Ghana. The facility, according to the authorities, is a step further in the mission of the University Hospital to provide excellent healthcare to the people. It comes at a time when facilities at the Komfo Anokye Teaching Hospital (KATH), Ghana’s second-largest health referral facility, were being overstretched, including the clinical training of Dental Students. The new…

Read More

WHO concludes joint Operational Planning Retreat with Ministry of Health and Sanitation

SIERRA LEONE – The World Health Organization Country Office in Sierra Leone has concluded a two-day high level technical and operational planning retreat with the Ministry of Health and Sanitation to develop and validate the key priorities for the Organization’s 2022-2023 biennial Operational Work Plan. The consultative process facilitated strategic discussions on aligning the Organization’s two years activities with the health priorities of the government of Sierra Leone. Every other year, Country Offices of the World Health Organization develop their operational plans informed by the Organization’s General Programme of Work.…

Read More

AI giant Exscientia files IPO, raises over US$460 million for drug research and development

UNITED KINGDOM – Exscientia’s initial public offering and private placement has raised US$464 million to fund its artificial intelligence-based approach to drug discovery and development. The new cash infusion follows a US$525 million fourth-round raise in April and a US$100 million third-round raise just a month earlier. Exscientia intends to develop its own drugs alongside a growing number of drug candidates licensed to other drugmakers, including Bristol-Myers Squibb (which recently signed a US$1.2 billion alliance with the Oxford, UK-based company), Sanofi, Bayer, Dainippon Sumitomo Pharma (DSP), and Evotec. The company’s…

Read More

Korean AI-driven drug developers seek expansion in overseas markets

KOREA – Korean AI-driven drug developers are establishing overseas branches or a wet lab to seek new business opportunities. Several AI-backed drug discovery companies have emerged in Korea to find new medicines. Standigm, Syntekabio, Deargen, Oncocross, Pharos iBio, Baobab AiBIO, PharmCADD, and AZothBio are among them. Cimplrx announced a joint development and licensing agreement with Dong-A ST in September to develop an innovative drug for central nervous system diseases, piqued the interest of the pharmaceutical industry. In addition, some AI-driven new drug developers have established a web lab, progressing to…

Read More

Medtronic’s AI surgery machine gets EU CE mark approval

IRELAND – Medtronic plc, the global leader in medical technology, announced today that the Hugo robotic-assisted surgery (RAS) system has received CE (Conformité Européenne) mark, allowing it to be sold in Europe. CE Mark approval is only available for urologic and gynecologic procedures, which account for roughly half of all robotic procedures performed today. Hugo RAS system plays a critical role in bringing the benefits of minimally invasive surgery, the first-ever in the world using the Hugo RAS system. CE Mark approval follows major milestones in the Hugo RAS system global…

Read More